1. Home
  2. PCVX vs SNX Comparison

PCVX vs SNX Comparison

Compare PCVX & SNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • SNX
  • Stock Information
  • Founded
  • PCVX 2013
  • SNX 1980
  • Country
  • PCVX United States
  • SNX United States
  • Employees
  • PCVX N/A
  • SNX N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • SNX Retail: Computer Software & Peripheral Equipment
  • Sector
  • PCVX Health Care
  • SNX Technology
  • Exchange
  • PCVX Nasdaq
  • SNX Nasdaq
  • Market Cap
  • PCVX 4.4B
  • SNX 11.2B
  • IPO Year
  • PCVX 2020
  • SNX 2003
  • Fundamental
  • Price
  • PCVX $36.14
  • SNX $141.33
  • Analyst Decision
  • PCVX Strong Buy
  • SNX Strong Buy
  • Analyst Count
  • PCVX 10
  • SNX 9
  • Target Price
  • PCVX $136.50
  • SNX $140.89
  • AVG Volume (30 Days)
  • PCVX 1.5M
  • SNX 1.1M
  • Earning Date
  • PCVX 08-05-2025
  • SNX 06-24-2025
  • Dividend Yield
  • PCVX N/A
  • SNX 1.24%
  • EPS Growth
  • PCVX N/A
  • SNX 19.95
  • EPS
  • PCVX N/A
  • SNX 8.55
  • Revenue
  • PCVX N/A
  • SNX $60,007,297,000.00
  • Revenue This Year
  • PCVX N/A
  • SNX $4.63
  • Revenue Next Year
  • PCVX N/A
  • SNX $4.23
  • P/E Ratio
  • PCVX N/A
  • SNX $16.57
  • Revenue Growth
  • PCVX N/A
  • SNX 6.60
  • 52 Week Low
  • PCVX $27.66
  • SNX $92.23
  • 52 Week High
  • PCVX $121.06
  • SNX $145.10
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 57.77
  • SNX 72.44
  • Support Level
  • PCVX $31.79
  • SNX $140.25
  • Resistance Level
  • PCVX $36.89
  • SNX $144.17
  • Average True Range (ATR)
  • PCVX 1.51
  • SNX 3.40
  • MACD
  • PCVX 0.37
  • SNX 0.27
  • Stochastic Oscillator
  • PCVX 77.65
  • SNX 84.90

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About SNX TD SYNNEX Corporation

TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.

Share on Social Networks: